Sigma‐1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors

Adrenal chromaffin cells (ACCs) are the neuroendocrine arm of the sympathetic nervous system and key mediators of the physiological stress response. Acetylcholine (ACh) released from preganglionic splanchnic nerves activates nicotinic acetylcholine receptors (nAChRs) on chromaffin cells causing memb...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 143; no. 2; pp. 171 - 182
Main Authors Brindley, Rebecca L., Bauer, Mary Beth, Hartley, Nolan D., Horning, Kyle J., Currie, Kevin P.M.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Adrenal chromaffin cells (ACCs) are the neuroendocrine arm of the sympathetic nervous system and key mediators of the physiological stress response. Acetylcholine (ACh) released from preganglionic splanchnic nerves activates nicotinic acetylcholine receptors (nAChRs) on chromaffin cells causing membrane depolarization, opening voltage‐gated Ca2+ channels (VGCC), and exocytosis of catecholamines and neuropeptides. The serotonin transporter is expressed in ACCs and interacts with 5‐HT1A receptors to control secretion. In addition to blocking the serotonin transporter, some selective serotonin reuptake inhibitors (SSRIs) are also agonists at sigma‐1 receptors which function as intracellular chaperone proteins and can translocate to the plasma membrane to modulate ion channels. Therefore, we investigated whether SSRIs and other sigma‐1 receptor ligands can modulate stimulus‐secretion coupling in ACCs. Escitalopram and fluvoxamine (100 nM to 1 μM) reversibly inhibited nAChR currents. The sigma‐1 receptor antagonists NE‐100 and BD‐1047 also blocked nAChR currents (≈ 50% block at 100 nM) as did PRE‐084, a sigma‐1 receptor agonist. Block of nAChR currents by fluvoxamine and NE‐100 was not additive suggesting a common site of action. VGCC currents were unaffected by the drugs. Neither the increase in cytosolic [Ca2+] nor the resulting catecholamine secretion evoked by direct membrane depolarization to bypass nAChRs was altered by fluvoxamine or NE‐100. However, both Ca2+ entry and catecholamine secretion evoked by the cholinergic agonist carbachol were significantly reduced by fluvoxamine or NE‐100. Together, our data suggest that sigma‐1 receptors do not acutely regulate catecholamine secretion. Rather, SSRIs and other sigma‐1 receptor ligands inhibit secretion evoked by cholinergic stimulation because of direct block of Ca2+entry via nAChRs. Sigma‐1 receptors are intracellular chaperone proteins that can translocate to the plasma membrane to modulate various ion channels and cellular functions. We investigated the impact of several sigma‐1 receptor ligands including fluvoxamine (a selective serotonin reuptake inhibitor) on catecholamine secretion from adrenal chromaffin cells. Our data suggest that sigma‐1 receptors do not acutely regulate catecholamine secretion. Rather, sigma‐1 receptor ligands inhibited secretion evoked by cholinergic stimulation because of direct block of Ca2+entry via nicotinic acetylcholine receptors.
Bibliography:These authors contributed equally
DR. KEVIN CURRIE (Orcid ID : 0000-0002-0861-423X)
ISSN:0022-3042
1471-4159
DOI:10.1111/jnc.14149